Priority Date: 17.02.12 (US 201261600480P)

METHODS AND MATERIALS FOR GENERATING CD8+ T CELLS HAVING THE ABILITY TO RECOGNIZE CANCER CELLS EXPRESSING A HER2/NEU POLYPEPTIDE

  • Application ID: EP13749730
  • Status: GRANT OF PATENT INTENDED

Attorneys

operating since 1878
Headquarter in Boston and 11 offices
active in Legal Services
operating since 1878
Headquarter in Boston and 11 offices
active in Legal Services
operating since 2006
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Grund Intellectual Property Group is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 188 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 17.02.2012 - Priority Date (US 201261600480P)
  • 22.08.2013 - Publication A1 (WO2013123424)
  • 24.12.2014 - Publication A1 (EP2814836)

IPC Classification